ABC borderline resectable pancreatic cancer research hub

A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial)

This study is looking at a new treatment called MesoPher for a type of pancreatic cancer that's hard to treat but might be removable by surgery. It aims to see if this new treatment can help people live longer and prevent the cancer from coming back.